Marinus Pharma Inks $60M Stock Sales Deal With JMP

Marinus Pharmaceuticals (NASDAQ:MRNS) has filed a prospectus for a $250M mixed shelf offering.

It has also entered into an agreement with JMP Securities for the at-the-market sale of up to $60M of its common stock. JMP will earn a 3% commission for its efforts.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.